Search

After the close Friday, we learned that the Senate banking committee has scheduled a vote on key cannabis sector banking reform on September 27.

Of course, we do not know that the committee will stick to its schedule. But it is likely, so I will assume that will be the case. This timing suggests a possible course of action for cannabis holdings.

The story remains the same for the market this week: The major indexes are all down (in the 1% to 2% range), which keeps the intermediate-term trend pointed down (every major index we look at is below its 50-day moving averages). Going along with that, the vast majority of individual stocks (about 80% of the S&P 1500) are in the same boat and hundreds of stocks are hitting new lows most days while only a couple handfuls hit new highs.

Charlie Munger, a legendary investor and former vice chair of Berkshire Hathaway, recently passed away at 99. Here are a few lessons he left us with, and his final investments.

The three leading indexes again made a run at new highs last week as the S&P 500 gained 1.75%, the Dow rallied 0.7% and the Nasdaq added 2.88%.

In investing, like football, competition is tough, rivalries are strong and the money and stakes are high. So, what lessons can investors learn from the NFL Playoffs?

The bulls once again pushed the market higher last week as the S&P 500 gained 0.77%, the Dow was the big winner with a rally of 2.42%, and the Nasdaq rose marginally by 0.38%.

Despite some early-in-the-week wobbles, the bulls were able to rally into the close of the week and again tack on gains. For the week the S&P 500 gained 0.8%, the Dow was unchanged, and the Nasdaq rose by 0.7%.

After two years of bear markets, chops, narrow rallies and fits and starts, evidence is building that growth stocks should lead the way once again.

The month of July brought the strongest stock rally since 2020, although sentiment remains fairly weak. So where do we go from here?

Value investing has lagged growth investing for decades, but recent declines in the market are good news for contrarian investors.

The good times for the bulls continued as the S&P 500 rose for a fifth consecutive week, its longest such streak since November 2021, and it was also the best week for the S&P 500 since March.

You may think it’s impossible to find growth stocks trading at value prices, but you can. If you know where to look.

It’s been a very nice snapback week for the market as a whole, with all of the major indexes up, led by the laggards of the prior week—the broader indexes—which have encouragingly pushed back toward (or in some cases out above) their recent highs, and the market is likely to build on its gains after this morning’s inflation report. All in all, this keeps the evidence positive: The market’s intermediate-term trend is up, and while the broad market has been having the occasional wobble, it’s still in the healthy camp.

The answer to the question “what are micro-cap stocks?” is simple, but what’s more important is why they belong in investors’ portfolios.

Led by mega-cap tech stocks, the indexes tacked on modest gains last week. The S&P 500 rose 1%, the Dow added 0.84%, and the Nasdaq gained 0.7%.

For the first time in weeks, and maybe even months, the market’s advance felt broader as more and more stocks participated in the market rally. That, as well as the VIX getting clobbered, has me encouraged … for now.

It can be hard to navigate an uncertain market like we’ve got now. But finding a system can improve your results; here’s Cabot’s.

Back on October 7 intraday, I recommended selling our entire position in Tilray Brands (TLRY) at 3.47; our entire position in ETFMG Alternative Harvest ETF (MJ) at 5.48; $7,000 of Curaleaf (CURLF) at 6.33; and $7,000 of Green Thumb (GTBIF) at 13.35.

Earnings Recap: ABNB, SPT, FSR, AXNX, ARIS